Live Breaking News & Updates on Cardiovascular Risk

Stay updated with breaking news from Cardiovascular risk. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Unveiling Cardiovascular Disparities in Lp(a)

Michael D. Shapiro, DO, and Jaime Murillo, MD, discuss the implications of high Lp(a) levels in the US population, racial disparities, and tailored interventions for high-risk groups. ....

Jaime Murillo , Michaeld Shapiro , Cardiovascular Risk , Racial Disparities , Atherosclerotic Cardiovascular Disease , Population Health , Elevated Lpla Levels , Cardiovascular Risk Assessment , Minority Populations , Tailored Interventions , Racial Health Disparities ,

French Drugmaker Servier Ordered to Pay $471 Million for Mediator Scandal

Drugmaker Servier must pay more than 430 million euros ($471 million) in connection with weight-loss pill Mediator, a French court ruled on Wednesday, saying the company was. ....

France General , United States , Lisa Shumaker , Tassilo Hummel , Piotr Lipinski , Servier Chief Executive Jean Philippe Seta , Weight Management , Pharmaceutical Quality Control , Cv Risk , Cardiovascular Risk , V Risk Factors , Cardiovascular Risk Factors , Cardiovascular Risk Management , Drug Regulation , Cardiovascular Disease , Vd Cardiovascular Disease , Weight Loss , Malpractice Insurance ,

Reducing CVD Morbidity and Mortality in Psoriasis and PsA

Only a minority of patients with psoriatic disease know about their increased risks. ....

United States , Joelm Gelfand , Johns Barbieri , Alexisr Ogdie Beatty , Michaels Garshick , Joel Gelfand , York University Langone Health , National Ambulatory Medical Care , National Psoriasis Foundation , American Academy Of Dermatology , Langone Health , American Academy , New York University Langone Health , National Ambulatory Medical Care Survey , Advanced Acne Therapeutics Clinic , Psoriatic Arthritis , Rthropathic Psoriasis , Psoriatic Arthropathy , Cv Risk , Cardiovascular Risk , V Risk Factors , Cardiovascular Risk Factors , Cardiovascular Risk Management , Prostate Specific Antigen , Sa Prostate Specific Antigen , Ipid Management ,

No Impact of Race on Cardiovascular Risk Calculations

A recent study adds to the growing body of evidence questioning the role of race-based stratification for specific clinical measures. ....

New York , United States , Arnab Ghosh , Weill Cornell Medical College , Presbyterian Weill Cornell Medical Center , Racial Differences , Weill Cornell Medical Center , Cv Risk , Cardiovascular Risk , V Risk Factors , Cardiovascular Risk Factors , Cardiovascular Risk Management , Social Determinants Of Health , Social Determinants Of Health Sdoh , Atherosclerotic Heart Disease , Therosclerotic Cardiovascular Disease , Oronary Heart Disease , Schemic Heart Disease , Coronary Artery Disease ,

FDA Updates Labels for Two Cholesterol-Lowering Agents

New bempedoic acid and bempedoic acid/ezetimibe labels add primary hyperlipidemia and remove the maximally tolerated statin requirement and statement on the effect on mortality. ....

Drug Administration , Medscape Medical , Prescription Drug User Fee Act , Ipid Management , Cv Risk , Cardiovascular Risk , V Risk Factors , Cardiovascular Risk Factors , Cardiovascular Risk Management , Cardiometabolic Risk , Cardiometabolic Risk Factors , Hyperlipidemia Hyperlipidaemia , Lipid Lowering Drugs , Vldl Cholesterol , Low Density Lipoprotein Cholesterol , Atherosclerotic Heart Disease , Therosclerotic Cardiovascular Disease , Oronary Heart Disease ,